TheraRadar

Pharma Intelligence, Simplified

Landscape → Hepatology

Liver Failure

55 clinical trials

29 active
/
55 total (since 2015)
16
Phase 1 Active
27 total
16
Phase 2 Active
27 total
5
Phase 3 Active
10 total
1
Phase 4 Active
4 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Yaqrit Ltd 2 0 0
Quell Therapeutics Limited 1 0 0
eGenesis, INC 1 0 0
Gilead 1 0 0
Beijing Continent Pharmaceutical Co, Ltd. 1 0 0
Miromatrix Medical Inc. 1 0 0
Dr. F. Köhler Chemie GmbH 1 0 0
Hexaell Biotech Co., Ltd. 1 0 0
Genfit 0 1 2
NCT07347275 NOT YET RECRUITING
A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.
Yaqrit Ltd n=72
NCT03627013 RECRUITING
Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
Dr. F. Köhler Chemie GmbH n=362
NCT07075315 NOT YET RECRUITING
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
Institute of Liver and Biliary Sciences, India n=100
NCT06884904 NOT YET RECRUITING
Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF
National Engineering Center of Cell Products n=96
NCT06815770 NOT YET RECRUITING
Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal Bleed
Institute of Liver and Biliary Sciences, India n=60
NCT03702920 TERMINATED
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%
Grifols Therapeutics LLC n=275
NCT02837939 WITHDRAWN
Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction
Martin Janičko
NCT02584283 COMPLETED
Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation
Robert J. Porte n=157
NCT02786836 COMPLETED
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
University of Texas Southwestern Medical Center n=76
NCT02552901 WITHDRAWN
Cardiox Liver Function Test Pivotal Trial
Cardiox Corporation

Data: ClinicalTrials.gov